📑Furnizare medicamente uz uman
Procurement process summary
This process is to purchase Furnizare medicamente uz uman.
This contract was awarded by 🇷🇴 Penitenciar Spital Bucuresti Jilava for an amount of RON 31,535 to 1 supplier. It was published on not reported through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇷🇴 Penitenciar Spital Bucuresti Jilava Buying unitnot reported Publication datenot reported Contest statusnot reported Descriptionnot reportedAwards
This award was granted to S.C. NEXT PHARMA S.A. by Penitenciar Spital Bucuresti Jilava for an amount of RON 31,535. The procurement process was conducted through direct for the category of goods. This is award number 2.
This contract has multiple awards. This is award number 2. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇷🇴 S.C. NEXT PHARMA S.A. | RON 31,535 | 2 |
Market context and opportunities
The execution of this contract allows the entity Penitenciar Spital Bucuresti Jilava to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberRO_ocds-70d2nz-c3f7a262-2475-4619-965f-8958a7077605-award-2Publication datenot reportedContract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalitydirectMethod detailsNegociere fara publicare prealabilaStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
